SQI Diagnostics Abandons Bid to Acquire Scienion, Withdraws IPO
October 11, 2011
SQI Diagnostics Abandons Bid to Acquire Scienion, Withdraws IPO
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Array-Based Tests Advance as Dx Firms Engage FDA, Raise Capital, Report Revenue Growth
May 15, 2012 / BioArray News - SQI Diagnostics Amends Purchase Deal of Scienion to Push Back Termination Date
September 27, 2011 / GenomeWeb Daily News - SQI Buying Microarray Firm Scienion for $15.6M, and Stock
July 5, 2011 / GenomeWeb Daily News - SQI, Algorithme Pharma Develop Heparin Screening Assay, Plan Near-Term Commercial Launch
March 26, 2013 / BioArray News - Spanish Researchers Using Scienion Arrayers to Develop Nanomechanical Biosensor Platform
February 5, 2013 / BioArray News